Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lifestance Health Group ( (LFST) ) has issued an announcement.
On August 19, 2025, William Miller resigned from the board of directors of LifeStance Health Group, Inc., with no disagreements cited as the reason. Following his resignation, Sarah Personette was appointed to the board on August 20, 2025, and was granted an initial award of 74,766 restricted stock units under the company’s 2021 Equity Incentive Plan, contingent on her continued service.
The most recent analyst rating on (LFST) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Lifestance Health Group stock, see the LFST Stock Forecast page.
Spark’s Take on LFST Stock
According to Spark, TipRanks’ AI Analyst, LFST is a Neutral.
Lifestance Health Group’s overall stock score is driven by strong earnings call performance and positive technical indicators, despite challenges in profitability and valuation. The company’s ability to exceed guidance and achieve record free cash flow are significant strengths, while the negative P/E ratio and lack of dividend yield are notable weaknesses.
To see Spark’s full report on LFST stock, click here.
More about Lifestance Health Group
Average Trading Volume: 2,568,341
Technical Sentiment Signal: Buy
Current Market Cap: $2.08B
For an in-depth examination of LFST stock, go to TipRanks’ Overview page.